SCHOTT Pharma AG & Co. KGaA (1SXP.F)
EUR 23.72
(0.08%)
EUR 23.72
(0.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 192.38 Million EUR | 17.04% |
| 2022 | 164.37 Million EUR | 28.76% |
| 2021 | 127.65 Million EUR | 29.98% |
| 2020 | 98.21 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 58 Million EUR | 53.5% |
| 2024 Q2 | 28.47 Million EUR | -50.9% |
| 2024 Q3 | 58 Million EUR | 103.49% |
| 2023 Q2 | 61.72 Million EUR | 38.55% |
| 2023 FY | 192.38 Million EUR | 17.04% |
| 2023 Q3 | 42.12 Million EUR | -31.76% |
| 2023 Q1 | 44.54 Million EUR | 25.6% |
| 2023 Q4 | 37.78 Million EUR | -10.3% |
| 2022 Q4 | 35.46 Million EUR | 0.0% |
| 2022 FY | 164.37 Million EUR | 28.76% |
| 2021 FY | 127.65 Million EUR | 29.98% |
| 2020 FY | 98.21 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Carl Zeiss Meditec AG | 327.13 Million EUR | 41.192% |
| Fielmann Aktiengesellschaft | 286.54 Million EUR | 32.862% |
| Gerresheimer AG | 213.39 Million EUR | 9.845% |
| Sartorius Aktiengesellschaft | 543.2 Million EUR | 64.583% |
| Sartorius Aktiengesellschaft | 543.2 Million EUR | 64.583% |